ACHV: Receives FDA Response
Achieve Life Sciences Receives FDA's Complete Response Letter Regarding New Drug Application For Cytisinicline; FDA Identifies No Deficiencies Regarding Clinical Efficacy, Safety Of Cytisinicline
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
2 results loaded, newest first. End of these results.
ACHV Receives FDA Letter
ACHV - Achieve Life Sciences Receives Complete Response Letter from FDA for Cytisinicline NDA